These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 20802264)
21. The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation. Holmes DR; Kim LJ; Brooks MM; Kip KE; Schaff HV; Detre KM; Frye RL; J Thorac Cardiovasc Surg; 2007 Jul; 134(1):38-46, 46.e1. PubMed ID: 17599484 [TBL] [Abstract][Full Text] [Related]
22. Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: an analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT). Berry C; Pieper KS; White HD; Solomon SD; Van de Werf F; Velazquez EJ; Maggioni AP; Califf RM; Pfeffer MA; McMurray JJ Eur Heart J; 2009 Jun; 30(12):1450-6. PubMed ID: 19346225 [TBL] [Abstract][Full Text] [Related]
23. Observational comparison of event-free survival with medical and surgical therapy in patients with coronary artery disease. 20 years of follow-up. Muhlbaier LH; Pryor DB; Rankin JS; Smith LR; Mark DB; Jones RH; Glower DD; Harrell FE; Lee KL; Califf RM Circulation; 1992 Nov; 86(5 Suppl):II198-204. PubMed ID: 1424000 [TBL] [Abstract][Full Text] [Related]
24. Early and long-term outcomes after surgical and percutaneous myocardial revascularization in patients with non-ST-elevation acute coronary syndromes and unprotected left main disease. Buszman PP; Bochenek A; Konkolewska M; Trela B; Kiesz RS; Wilczyński M; Cisowski M; Krejca M; Banasiewicz-Szkróbka I; Krol M; Kondys M; Wiernek S; Orlik B; Martin JL; Tendera M; Buszman PE J Invasive Cardiol; 2009 Nov; 21(11):564-9. PubMed ID: 19901409 [TBL] [Abstract][Full Text] [Related]
29. Effect of peripheral arterial disease on in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction. Jeremias A; Gruberg L; Patel J; Connors G; Brown DL Am J Cardiol; 2010 May; 105(9):1268-71. PubMed ID: 20403477 [TBL] [Abstract][Full Text] [Related]
30. Usefulness of noncoronary vascular disease in predicting adverse events in the year following percutaneous coronary intervention. Naidu SS; Vlachos H; Faxon D; Jacobs AK; Selzer F; Detre K; Wilensky RL Am J Cardiol; 2005 Mar; 95(5):575-80. PubMed ID: 15721094 [TBL] [Abstract][Full Text] [Related]
31. Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study. von Eynatten M; Breitling LP; Roos M; Baumann M; Rothenbacher D; Brenner H Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2327-35. PubMed ID: 22679309 [TBL] [Abstract][Full Text] [Related]
32. Impact of multivessel coronary artery disease on outcome after isolated minimally invasive bypass grafting of the left anterior descending artery. Lichtenberg A; Klima U; Paeschke H; Pichlmaier M; Ringes-Lichtenberg S; Walles T; Goerler H; Haverich A Ann Thorac Surg; 2004 Aug; 78(2):487-91. PubMed ID: 15276503 [TBL] [Abstract][Full Text] [Related]
33. [The best of epidemiology and cardiovascular prevention in 2006]. Thomas D; Collet JP; Cottin Y; Cournot M; Ducimetière P; Ferrières J; Paillard F; Valensi P; Zeller M; Cambou JP Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():57-64. PubMed ID: 17405566 [TBL] [Abstract][Full Text] [Related]
34. Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data. Weiss ES; Chang DD; Joyce DL; Nwakanma LU; Yuh DD J Thorac Cardiovasc Surg; 2008 Mar; 135(3):503-11, 511.e1-3. PubMed ID: 18329460 [TBL] [Abstract][Full Text] [Related]
35. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. Bhatt DL; Steg PG; Ohman EM; Hirsch AT; Ikeda Y; Mas JL; Goto S; Liau CS; Richard AJ; Röther J; Wilson PW; JAMA; 2006 Jan; 295(2):180-9. PubMed ID: 16403930 [TBL] [Abstract][Full Text] [Related]
36. Effects of adherence to guidelines for the control of major cardiovascular risk factors on outcomes in the REduction of Atherothrombosis for Continued Health (REACH) Registry Europe. Cacoub PP; Zeymer U; Limbourg T; Baumgartner I; Poldermans D; Röther J; Bhatt DL; Steg PG; Heart; 2011 Apr; 97(8):660-7. PubMed ID: 21357372 [TBL] [Abstract][Full Text] [Related]
37. Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis. Udell JA; Steg PG; Scirica BM; Eagle KA; Ohman EM; Goto S; Alsheikh-Ali AA; Porath A; Corbalan R; Umez-Eronini AA; Hoffman EB; Wilson PW; Bhatt DL; Eur J Prev Cardiol; 2014 Dec; 21(12):1531-40. PubMed ID: 23918840 [TBL] [Abstract][Full Text] [Related]
38. Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Cavender MA; Steg PG; Smith SC; Eagle K; Ohman EM; Goto S; Kuder J; Im K; Wilson PW; Bhatt DL; Circulation; 2015 Sep; 132(10):923-31. PubMed ID: 26152709 [TBL] [Abstract][Full Text] [Related]